Coronary artery bypass surgery perioperative management of myocardial ischemia

Coronary Artery Bypass Surgery Microchapters
Home
Patient Information
Overview
Pathophysiology
Saphenous Vein Graft Disease
Other Non-Atherosclerotic Saphenous Vein Graft Diseases
Indications for CABG
Prognosis
Diagnosis
Imaging in the Patient Undergoing CABG
Chest X Ray
Angiography
CT Angiography
MRI Angiography
Trans-Esophageal Echocardiography
Treatment
Goals of Treatment
Perioperative Management
Perioperative Monitoring
Electrocardiographic Monitoring
Pulmonary Artery Catheterization
Central Nervous System Monitoring
Surgical Procedure
Anesthetic Considerations
Intervention in left main coronary artery disease
The Traditional Coronary Artery Bypass Grafting Procedure (Simplified)
Minimally Invasive CABG
Hybrid coronary revascularization
Conduits Used for Bypass
Videos on Spahenous Vein Graft Harvesting
Videos on Coronary Artery Bypass Surgery
Post-Operative Care and Complications
Pharmacotherapy in patients undergoing CABG CABG
Special Scenarios
Anomalous Coronary Arteries
COPD/Respiratory Insufficiency
Existing Renal Disease
Concomitant Valvular Disease
Previous Cardiac Surgery
Menopause
Carotid Disease evaluation before surgery
Coronary artery bypass surgery perioperative management of myocardial ischemia On the Web
Most recent articles
Most cited articles
Review articles
CME programs
powerpoint slides
Images
Ongoing trials at clinical trials.gov
US National guidelines clearinghouse
NICE guidance
FDA on Coronary artery bypass surgery perioperative management of myocardial ischemia
CDC on Coronary artery bypass surgery perioperative management of myocardial ischemia
Coronary artery bypass surgery perioperative management of myocardial ischemia in the news
Blogs on Coronary artery bypass surgery perioperative management of myocardial ischemia|-
Directions to Hospitals Performing Coronary artery bypass surgery perioperative management of myocardial ischemia
Risk calculators for Coronary artery bypass surgery perioperative management of myocardial ischemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]

ACCF/AHA Guidelines for Perioperative Myocardial Dysfunction

“

Class I 1. In the absence of severe, symptomatic aorto-iliac occlusive disease or PAD, the insertion of an intraaortic balloon is reasonable to reduce mortality rate in CABG patients who are considered to be at high risk (eg, those who are undergoing reoperation or have LVEF <30% or left main CAD).1021–1026 (Level of Evidence: B) 2. Measurement of biomarkers of myonecrosis (eg, creatine kinase-MB, troponin) is reasonable in the first 24 hours after CABG.200 (Level of Evidence: B)

”

Guidelines Resources

• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines